Patent Yard Sign in
Expired European patentEurope

Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form

EP 1017390 B1 · Applicant: Kos Life Sciences, Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 31, 1998 and granted April 18, 2007. A European patent lasts at most 20 years from filing, so its term ended July 31, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by January 31, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJuly 31, 1998
PublishedJuly 12, 2000
GrantedApril 18, 2007
Term endedJuly 31, 2018
Application numberEP 98938228
Classification (CPC)A61P29/00 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedJuly 31, 1998PublishedJuly 12, 2000Patent grantedApril 18, 2007Term endedJuly 31, 2018

Sources & verification